Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 7,694 shares at $14.03 ($108K) on 2025-08-08, disclosed to the SEC on 2025-08-12.
Scheduled sale ($108k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.03 | 3,847 | $54K | 50.0% |
| 2 | $14.03 | 3,847 | $54K | 50.0% |
| Total | $14.03 avg | 7,694 | $108K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |